C Treanor1, T Kyaw2, M Donnelly2,3. 1. Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Institute of Clinical Sciences-B Building, Royal Victoria Hospital Site, Queen's University Belfast, Grosvenor Road, Belfast, Northern Ireland, BT12 6BJ, UK. c.treanor@qub.ac.uk. 2. Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Institute of Clinical Sciences-B Building, Royal Victoria Hospital Site, Queen's University Belfast, Grosvenor Road, Belfast, Northern Ireland, BT12 6BJ, UK. 3. UKCRC Centre of Excellence for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland, UK.
Abstract
PURPOSE: The purpose of the study is to systematically review and synthesise randomised controlled trials investigating the effectiveness of prehabilitation compared to usual care for newly diagnosed, adult-onset cancer patients. METHODS: MEDLINE, EMBASE, PsycINFO, CINAHL and SSCI were searched up to April 2017. Studies were included if disease-related, treatment-related, patient-reported and health service utilisation outcomes were assessed. Two reviewers independently reviewed and appraised the risk of bias of each study. RESULTS: Eighteen studies were included. Interventions comprised one or more of the following components: psychological support, education and exercise. Meta-analyses found that pelvic floor muscle training (PFMT) significantly increased odds of continence at 3 months (OR = 3.29, 95% CI = 1.57-6.91), but did not significantly reduce daily pad use at 6 months post-surgery Mean Difference (MD)= ( = - 0.96, 95% CI = - 2.04-0.12) for prostate cancer patients. Although quality of life improved due to PFMT, functional ability or distress did not. Further meta-analyses indicated that pre-surgical exercise significantly reduced length of hospital stay (MD = - 4.18, 95% CI = - 5.43-- 2.93) and significantly lowered odds of post-surgery complications (OR = 0.25, 95% CI = 0.10-0.66) for lung cancer patients. Psychology-based prehabilitation significantly improved mood, physical well-being and immune function for prostate cancer patients and improved fatigue and psychological outcomes and a trend for better quality of life among breast cancer patients. Risk of bias was high for most studies. CONCLUSIONS: Prehabilitation appears to benefit cancer patients. Rigorous trials are needed to investigate the effectiveness of prehabilitation among other cancer sites and other related effects. The cost-effectiveness of prehabilitation remains unanswered. IMPLICATIONS FOR CANCER SURVIVORS: Providing interventions earlier in the care pathway may lead to better outcomes for patients during survivorship.
PURPOSE: The purpose of the study is to systematically review and synthesise randomised controlled trials investigating the effectiveness of prehabilitation compared to usual care for newly diagnosed, adult-onset cancer patients. METHODS: MEDLINE, EMBASE, PsycINFO, CINAHL and SSCI were searched up to April 2017. Studies were included if disease-related, treatment-related, patient-reported and health service utilisation outcomes were assessed. Two reviewers independently reviewed and appraised the risk of bias of each study. RESULTS: Eighteen studies were included. Interventions comprised one or more of the following components: psychological support, education and exercise. Meta-analyses found that pelvic floor muscle training (PFMT) significantly increased odds of continence at 3 months (OR = 3.29, 95% CI = 1.57-6.91), but did not significantly reduce daily pad use at 6 months post-surgery Mean Difference (MD)= ( = - 0.96, 95% CI = - 2.04-0.12) for prostate cancer patients. Although quality of life improved due to PFMT, functional ability or distress did not. Further meta-analyses indicated that pre-surgical exercise significantly reduced length of hospital stay (MD = - 4.18, 95% CI = - 5.43-- 2.93) and significantly lowered odds of post-surgery complications (OR = 0.25, 95% CI = 0.10-0.66) for lung cancer patients. Psychology-based prehabilitation significantly improved mood, physical well-being and immune function for prostate cancer patients and improved fatigue and psychological outcomes and a trend for better quality of life among breast cancer patients. Risk of bias was high for most studies. CONCLUSIONS: Prehabilitation appears to benefit cancer patients. Rigorous trials are needed to investigate the effectiveness of prehabilitation among other cancer sites and other related effects. The cost-effectiveness of prehabilitation remains unanswered. IMPLICATIONS FOR CANCER SURVIVORS: Providing interventions earlier in the care pathway may lead to better outcomes for patients during survivorship.
Authors: J J Dronkers; H Lamberts; I M M D Reutelingsperger; R H Naber; C M Dronkers-Landman; A Veldman; N L U van Meeteren Journal: Clin Rehabil Date: 2010-06-08 Impact factor: 3.477
Authors: William R Carroll; Julie L Locher; Cheri L Canon; Isaac A Bohannon; Nancy L McColloch; J Scott Magnuson Journal: Laryngoscope Date: 2008-01 Impact factor: 3.325
Authors: Priya Brahmbhatt; Catherine M Sabiston; Christian Lopez; Eugene Chang; Jack Goodman; Jennifer Jones; David McCready; Ian Randall; Sarah Rotstein; Daniel Santa Mina Journal: Front Oncol Date: 2020-09-25 Impact factor: 6.244
Authors: William A Wood; M Weaver; A E Smith-Ryan; E D Hanson; T C Shea; C L Battaglini Journal: Support Care Cancer Date: 2020-02-28 Impact factor: 3.603
Authors: Kelly J Lafaro; Dan J Raz; Jae Y Kim; Sherry Hite; Nora Ruel; Gouri Varatkar; Loretta Erhunmwunsee; Laleh Melstrom; Byrne Lee; Gagandeep Singh; Yuman Fong; Virginia Sun Journal: Support Care Cancer Date: 2019-12-16 Impact factor: 3.603
Authors: Ruth Elisa Eyl; Melissa S Y Thong; Prudence R Carr; Lina Jansen; Lena Koch-Gallenkamp; Michael Hoffmeister; Jenny Chang-Claude; Hermann Brenner; Volker Arndt Journal: BMC Cancer Date: 2020-05-18 Impact factor: 4.430
Authors: James L Rogers; Elizabeth Vera; Alvina Acquaye; Nicole Briceno; Varna Jammula; Amanda L King; Heather Leeper; Martha M Quezado; Javier Gonzalez Alarcon; Lisa Boris; Eric Burton; Orieta Celiku; Anna Choi; Alexa Christ; Sonja Crandon; Ewa Grajkowska; Nicole Leggiero; Nicole Lollo; Marta Penas-Prado; Jennifer Reyes; Christine Siegel; Brett J Theeler; Michael Timmer; Kathleen Wall; Jing Wu; Kenneth Aldape; Mark R Gilbert; Terri S Armstrong Journal: Neurooncol Pract Date: 2021-04-10